[go: up one dir, main page]

PL346796A1 - Methods of downmodulating the immune response to therapeutic proteins - Google Patents

Methods of downmodulating the immune response to therapeutic proteins

Info

Publication number
PL346796A1
PL346796A1 PL99346796A PL34679699A PL346796A1 PL 346796 A1 PL346796 A1 PL 346796A1 PL 99346796 A PL99346796 A PL 99346796A PL 34679699 A PL34679699 A PL 34679699A PL 346796 A1 PL346796 A1 PL 346796A1
Authority
PL
Poland
Prior art keywords
downmodulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
PL99346796A
Other languages
English (en)
Inventor
Jiahua Qian
Leon W Hoyer
Mary Collins
Gary S Gray
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of PL346796A1 publication Critical patent/PL346796A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL99346796A 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins PL346796A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21

Publications (1)

Publication Number Publication Date
PL346796A1 true PL346796A1 (en) 2002-02-25

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99346796A PL346796A1 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Country Status (21)

Country Link
EP (1) EP1115423A1 (lt)
JP (1) JP2002526455A (lt)
KR (1) KR20010085830A (lt)
CN (1) CN1331602A (lt)
AU (1) AU761206B2 (lt)
BR (1) BR9913991A (lt)
CA (1) CA2343916A1 (lt)
CZ (1) CZ20011021A3 (lt)
EA (1) EA005236B1 (lt)
HK (1) HK1039059A1 (lt)
HU (1) HUP0103960A3 (lt)
IL (1) IL142069A0 (lt)
LT (1) LT4920B (lt)
LV (1) LV12768B (lt)
MX (1) MXPA01002898A (lt)
NO (1) NO20011412L (lt)
NZ (1) NZ511034A (lt)
PL (1) PL346796A1 (lt)
SI (1) SI20626A (lt)
WO (1) WO2000016801A1 (lt)
ZA (1) ZA200103156B (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
AU2001261735B2 (en) * 2000-05-19 2006-09-21 The Center For Blood Research, Inc. Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
EP1636579A4 (en) * 2003-06-10 2011-10-05 Smiths Detection Inc SENSOR ASSEMBLY
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
MX9203440A (es) 1985-04-12 1992-07-01 Genetics Inst Proteinas procoagulantes novedosas.
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
DE122007000078I2 (de) 1991-06-27 2011-01-13 Bristol Myers Squibb Co CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
EP0776217A1 (en) * 1994-08-19 1997-06-04 Novo Nordisk A/S A method of treating a patient with a biologically active compound
CA2200869A1 (en) * 1994-10-19 1996-05-02 Bruce C. Trapnell Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
WO1997034633A1 (en) * 1996-03-20 1997-09-25 Bristol-Myers Squibb Company Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
CZ244399A3 (cs) * 1997-01-10 1999-10-13 Biogen, Inc. Použití sloučeniny anti-CD40L pro výrobu léku pro léčení imunologických onemocnění
IL133305A0 (en) * 1997-06-20 2001-04-30 Biogen Inc Use of a cd40:cd154 binding interruptor for treating protein inhibitor syndrome
US8112896B2 (en) 2009-11-06 2012-02-14 Hexagon Metrology Ab Articulated arm

Also Published As

Publication number Publication date
EA200100385A1 (ru) 2001-10-22
HK1039059A1 (zh) 2002-04-12
CA2343916A1 (en) 2000-03-30
MXPA01002898A (es) 2002-06-04
EP1115423A1 (en) 2001-07-18
HUP0103960A2 (hu) 2002-02-28
SI20626A (sl) 2002-02-28
LT2001045A (lt) 2002-01-25
LV12768B (lv) 2002-06-20
LT4920B (lt) 2002-06-25
IL142069A0 (en) 2002-03-10
BR9913991A (pt) 2001-07-03
ZA200103156B (en) 2002-07-18
AU6057899A (en) 2000-04-10
KR20010085830A (ko) 2001-09-07
CZ20011021A3 (cs) 2001-10-17
JP2002526455A (ja) 2002-08-20
NO20011412L (no) 2001-05-16
LV12768A (en) 2001-12-20
AU761206B2 (en) 2003-05-29
CN1331602A (zh) 2002-01-16
NO20011412D0 (no) 2001-03-20
NZ511034A (en) 2004-03-26
HUP0103960A3 (en) 2003-09-29
WO2000016801A9 (en) 2000-10-26
WO2000016801A1 (en) 2000-03-30
EA005236B1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
FI971332A7 (fi) Suihkukuivatut mikropartikkelit terapeuttisina vehikkeleinä
IL135673A0 (en) Therapeutic uses of quinoline derivatives
EP1033994A4 (en) METHOD FOR PRODUCING BIOGINKGO
ID28441A (id) Terapi untuk memperbaiki kesadaran
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9930443D0 (en) Novel use of heat shock proteins
HUP0103960A3 (en) Methods of downmodulating the immune response to therapeutic proteins
GB9822619D0 (en) Immune response stimulation
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB9727410D0 (en) Improvements relating to adjustable furniture
GB9727230D0 (en) Improvements relating to adjustable furniture
KR960025637U (ko) 간격조절이 용이한 콘넥터
NO965332D0 (no) Terapeutisk perparat
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline
GB9820388D0 (en) Improvements relating to furniture
TW315720U (en) Structure of treadmill also having the resupination function of human body
KR960013110U (ko) 신발의 바닥면에 착탈이 용이한 지압구
GB9606255D0 (en) The game of bridge companion
TW322782U (en) Structure improvement of walker
TW351186U (en) Improvement of exercise walker
TW369896U (en) Modified walker structure
HU9501133D0 (en) Device to make easier the claimbing of the stairs

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)